Employing the European Thyroid Imaging Reporting and Data System 2017 classification in a malignancy risk stratification system for thyroid nodules at Can Tho Oncology Hospital from 2021 to 2023

Vo Van Kha; Tran Thi Huong Ly; Pham Thi Thanh Hoa; Vo Huynh Nhu; Damas Hendriansyah; Nusratuddin Abdullah; Rudy B. Leonardy; Mardiah Tahir; Samrichard Rambulangi; Firdaus Hamid; Filomena Pietrantonio; Vera Kopsaj; Francesco Rosiello; Aurora Tomassoni; Luca Moriconi; Donatella Padua; Kiki Rizki Amelia; Efendi Lukas; Nurbani Bangsawan; Isharyah Sunarno; Retno Budiarti Farid; Sriwijaya Qadar; Rabab H. Elshaikh; Ashok Kumar Sah; Abdelrahman Mohamed Abukanna; Abdulrahman Algarni; Ammar Abdelmola; Hussam Ali Osman; Tagwa Yousif Elsayed Yousif; Elryah I. Ali; Hiba Ali; Ayman Hussein Alfeel; Thanh Long Nguyen; Victor Storm; Lam Toi Phung; Cong Thien Le; Thi Thu Ha Le; Thi Hoa Nguyen; Son Tung Vu; Thien Thang Tran; Minh Hanh Vu; Van Tuan Nguyen; Francesco Ventrella; Anna Belfiore; Antonio Greco; Franco Mastroianni; Salvatore Lenti; Domenico Ruggiero; Michele Cannone; Vincenzo Ostilio Palmieri; Massimo Errico; Giuseppe Mancia; Guido Grassi; Sverre E. Kjeldsen

doi:10.4081/itjm.2025.1852

Search

Search Results

##search.searchResults.foundPlural##

Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 3. Clinical issues

Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

99-109

08-05-2014

https://doi.org/10.4081/itjm.2014.400

2432

PDF: 1482

HTML: 752
Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 2. Misconceptions, doubts and critical aspects when using generic drugs in the real world

Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

88-98

08-05-2014

https://doi.org/10.4081/itjm.2014.399

2191

PDF: 2104

HTML: 1898
Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or knowledge? Part 1. Pharmacological issues

Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

80-87

08-05-2014

https://doi.org/10.4081/itjm.2014.398

1692

PDF: 1281

HTML: 975
Evaluation of the pharmacoeconomics of drugs used for the treatment of long-term complications of sulfur mustard

Yunes Panahi, Mostafa Ghanei, Milad Vakili Zarch, Zohreh Poursaleh, Shahram Parvin, Ramin Rezaee, Amirhossein Sahebkar

102-113

29-08-2016

https://doi.org/10.4081/itjm.2016.743

2357

PDF: 1020

HTML: 513
Equivalent/generic drugs use. To whom? When? How?

Andrea Fontanella

77-79

08-05-2014

https://doi.org/10.4081/itjm.2014.472

1163

PDF: 903

HTML: 267
Toward a sustainable and wise healthcare approach: potential contributions from hospital Internal Medicine Departments to reducing inappropriate medical spending

Roberto Nardi, Franco Berti, Leonardo M. Fabbri, Giuseppe Di Pasquale, Ido Iori, Giovanni Mathieu, Giorgio Vescovo, Andrea Fontanella, Antonino Mazzone, Mauro Campanini, Carlo Nozzoli, Dario Manfellotto, on behalf of the FADOI and their Friends in the FFA Project Group

65-81

24-04-2013

https://doi.org/10.4081/itjm.2013.65

2042

PDF: 1581

HTML: 825
Medication reconciliation as a tool for reducing polypharmacy at hospital discharge in Internal Medicine Wards

Paola Zuccheri, Federico Manfredi, Arianna Serra, Morena Borsari, Roberto Nardi, Angelo Pasquale, Biagio Sassone

232-237

17-01-2014

https://doi.org/10.4081/itjm.2014.432

2901

PDF: 1353

HTML: 1927
Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study

Filomena Pietrantonio, Francesco Rosiello, Matteo Ruggeri, Maria Sofia Cattaruzza, Antonio Vinci, Margherita Lordi, Enrica Cipriano

03-06-2024

https://doi.org/10.4081/itjm.2024.1737

1775

PDF: 594

HTML: 32
Nominalism in Medicine: the case of personalized medicine or precision medicine

Italo Portioli

417-423

28-11-2017

https://doi.org/10.4081/itjm.2017.841

1427

PDF: 899

HTML: 299
Clostridioides difficile infection in hospital and community settings: summary document of a multidisciplinary group

Anna Danise, Federica Furfaro, Gianni Gattuso, Nicola Lucio Liberato, Clara Mandelli, Giuseppe Mazzola, Bianca Osnaghi

07-02-2024

https://doi.org/10.4081/itjm.2024.1666

2368

PDF: 765

HTML: 106
Internal medicine network: a new way of thinking hospital-territory integration and public-private partnership

Filomena Pietrantonio, Emilio Scotti

85-94

28-10-2016

https://doi.org/10.4081/itjm.2016.764

2178

PDF: 1204

HTML: 650
More research is needed for generic drugs

Silvio Garattini

145

23-10-2012

https://doi.org/10.4081/itjm.2012.145

919

PDF: 601
Open questions on bioequivalence: the case of cholecalciferol

Antonio Marzo, Anna Barassi, Elisabetta Porro

156-159

19-09-2013

https://doi.org/10.4081/itjm.2013.156

2227

PDF: 1294

HTML: 1103
Hemophagocytic syndrome in a patient with disseminated tuberculosis: a case report

Vania Lombardo, Fania Puccia, Antonino Terranova, Andrea Affronti, Ada Maria Florena, Lydia Giannitrapani, Maurizio Soresi

61-66

20-03-2018

https://doi.org/10.4081/itjm.2018.932

1374

PDF: 1125

HTML: 278
Acute pancreatitis: confronting to improve

Daniela Tirotta, Alessandro Franco, Francesca Talarico

164-175

14-06-2017

https://doi.org/10.4081/itjm.2017.727

1373

PDF: 890

HTML: 374
Gender differences in ischemic stroke intra-hospital mortality: a systematic review

Tiziana Ciarambino, Orazio Valerio Giannico, Amalia Campanile, Antonella Fischetti, Elena Barabgelata, Imma Ambrosino, Ombretta Para, Cecilia Politi, Mauro Giordano

30-06-2021

https://doi.org/10.4081/itjm.2021.1378

1159

PDF: 549

HTML: 50

1 - 16 of 16 items

Search

Search Results

Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 3. Clinical issues

Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 2. Misconceptions, doubts and critical aspects when using generic drugs in the real world

Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or knowledge? Part 1. Pharmacological issues

Evaluation of the pharmacoeconomics of drugs used for the treatment of long-term complications of sulfur mustard

Equivalent/generic drugs use. To whom? When? How?

Toward a sustainable and wise healthcare approach: potential contributions from hospital Internal Medicine Departments to reducing inappropriate medical spending

Medication reconciliation as a tool for reducing polypharmacy at hospital discharge in Internal Medicine Wards

Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study

Nominalism in Medicine: the case of personalized medicine or precision medicine

Clostridioides difficile infection in hospital and community settings: summary document of a multidisciplinary group

Internal medicine network: a new way of thinking hospital-territory integration and public-private partnership

More research is needed for generic drugs

Open questions on bioequivalence: the case of cholecalciferol

Hemophagocytic syndrome in a patient with disseminated tuberculosis: a case report

Acute pancreatitis: confronting to improve

Gender differences in ischemic stroke intra-hospital mortality: a systematic review

authors

reviewers

indexing

Categories

Keywords